Protective effects of FCGR2A polymorphism in invasive pneumococcal diseases

Chest

Volumn 142, Issue 6, 2012, Pages 1474-1481

  Bouglé, Adrien ^a,b   Max, Adeline ^a,b   Mongardon, Nicolas ^a,b   Grimaldi, David ^a,b,c   Pène, Frédéric ^a,b,c   Rousseau, Christophe ^c   Chiche, Jean Daniel ^a,b,c   Bedos, Jean Pierre ^e   Vicaut, Eric ^a,d   Mira, Jean Paul ^a,b,c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Assistance Publique Hôpitaux de Paris ^*  (France)

^c INSTITUT COCHIN   (France)

^d HÔPITAL LARIBOISIÈRE   (France)

^e CENTRE HOSPITALIER DE VERSAILLES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; DNA; FC RECEPTOR IIA; HISTIDINE;

ADULT; AGE; AGED; AMINO ACID SUBSTITUTION; ARTICLE; ARTIFICIAL VENTILATION; BACTEREMIA; CAUCASIAN; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; FCGR2A GENE; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MORTALITY; PNEUMOCOCCAL MENINGITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTECTION; SEPSIS; SIMPLIFIED ACUTE PHYSIOLOGY SCORE; STREPTOCOCCUS PNEUMONIA;

EID: 84870611103     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-2516     Document Type: Article

References (43)

1. Berkley JA, Lowe BS, Mwangi I, et al. Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med. 2005;352(1):39-47. (Pubitemid 40075679)
2. van der Poll T, Opal SM. Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet. 2009;374(9700):1543-1556.
3. Bédos JP, Chevret S, Chastang C, Geslin P, Régnier B. Epidemiological features of and risk factors for infection by Streptococcus pneumoniae strains with diminished susceptibility to penicillin: findings of a French survey. Clin Infect Dis. 1996;22(1):63-72. (Pubitemid 26022014)
4. Levy MM, Dellinger RP, Townsend SR, et al Surviving Sepsis Campaign. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med. 2010;38(2):367-374.
5. van der Poll T, Opal SM. Host-pathogen interactions in sepsis. Lancet Infect Dis. 2008;8(1):32-43.
6. Suresh MV, Singh SK, Ferguson DA Jr, Agrawal A. Role of the property of C-reactive protein to activate the classical pathway of complement in protecting mice from pneumococcal infection. J Immunol. 2006;176(7):4369-4374. (Pubitemid 44264417)
7. Roy S, Knox K, Segal S, et al Oxford Pneumoccocal Surveillance Group. MBL genotype and risk of invasive pneumococcal disease: a case-control study. Lancet. 2002;359(9317):1569-1573. (Pubitemid 34621123)
8. Dahmer MK, Randolph A, Vitali S, Quasney MW. Genetic polymorphisms in sepsis. Pediatr Crit Care Med. 2005;6(suppl 3):S61-S73. (Pubitemid 40724255)
9. van Sorge NM, van der Pol WL, van de Winkel JG. FcgammaR polymorphisms: implications for function, disease susceptibility and immunotherapy. Tissue Antigens. 2003;61(3):189-202.
10. Warmerdam PA, van de Winkel JG, Gosselin EJ, Capel PJ. Molecular basis for a polymorphism of human Fc gamma receptor II (CD32). J Exp Med. 1990;172(1):19-25. (Pubitemid 20217241)
11. Warmerdam PA, van de Winkel JG, Vlug A, Westerdaal NA, Capel PJ. A single amino acid in the second Ig-like domain of the human Fc gamma receptor II is critical for human IgG2 binding. J Immunol. 1991;147(4):1338-1343.
12. Salmon JE, Edberg JC, Kimberly RP. Fc gamma receptor III on human neutrophils. Allelic variants have functionally distinct capacities. J Clin Invest. 1990;85(4):1287-1295. (Pubitemid 20123776)
13. Sanders LA, van de Winkel JG, Rijkers GT, et al. Fc gamma receptor IIa (CD32) heterogeneity in patients with recurrent bacterial respiratory tract infections. J Infect Dis. 1994;170(4):854-861.
14. Rodriguez ME, van der Pol WL, Sanders LA, van de Winkel JG. Crucial role of FcgammaRIIa (CD32) in assessment of functional anti- Streptococcus pneumoniae antibody activity in human sera. J Infect Dis. 1999;179(2):423-433. (Pubitemid 29086645)
15. Bredius RG, de Vries CE, Troelstra A, et al. Phagocytosis of Staphylococcus aureus and Haemophilus influenzae type B opsonized with polyclonal human IgG1 and IgG2 antibodies. Functional hFc gamma RIIa polymorphism to IgG2. J Immunol. 1993;151(3):1463-1472. (Pubitemid 23219284)
16. Bredius RG, Derkx BH, Fijen CA, et al. Fc gamma receptor IIa (CD32) polymorphism in fulminant meningococcal septic shock in children. J Infect Dis. 1994;170(4):848-853.
17. Platonov AE, Shipulin GA, Vershinina IV, Dankert J, van de Winkel JG, Kuijper EJ. Association of human Fc gamma RIIa (CD32) polymorphism with susceptibility to and severity of meningococcal disease. Clin Infect Dis. 1998;27(4):746-750. (Pubitemid 29244328)
18. van der Pol WL, Huizinga TW, Vidarsson G, et al. Relevance of Fcgamma receptor and interleukin-10 polymorphisms for meningococcal disease. J Infect Dis. 2001;184(12):1548-1555. (Pubitemid 33139740)
19. Smith I, Vedeler C, Halstensen A. FcgammaRIIa and FcgammaRIIIb polymorphisms were not associated with meningococcal disease in western Norway. Epidemiol Infect. 2003;130(2):193-199. (Pubitemid 36511957)
20. Yee AM, Phan HM, Zuniga R, Salmon JE, Musher DM. Association between FcgammaRIIa-R131 allotype and bacteremic pneumococcal pneumonia. Clin Infect Dis. 2000;30(1):25-28. (Pubitemid 30067057)
21. Yuan FF, Marks K, Wong M, et al. Clinical relevance of TLR2, TLR4, CD14 and FcgammaRIIA gene polymorphisms in Streptococcus pneumoniae infection. Immunol Cell Biol. 2008;86(3):268-270. (Pubitemid 351430807)
22. Yuan FF, Wong M, Pererva N, et al. FcgammaRIIA polymorphisms in Streptococcus pneumoniae infection. Immunol Cell Biol. 2003;81(3):192-195. (Pubitemid 36649265)
23. Endeman H, Cornips MC, Grutters JC, et al. The Fcgamma receptor IIA-R/R131 genotype is associated with severe sepsis in community-acquired pneumonia. Clin Vaccine Immunol. 2009;16(7):1087-1090.
24. Moens L, Van Hoeyveld E, Verhaegen J, De Boeck K, Peetermans WE, Bossuyt X. Fcgamma-receptor IIA genotype and invasive pneumococcal infection. Clin Immunol. 2006;118(1):20-23. (Pubitemid 43012042)
25. Solé-Violán J, García-Laorden MI, Marcos-Ramos JA, et al. The Fcγreceptor IIA-H/H131 genotype is associated with bacteremia in pneumococcal community-acquired pneumonia. Crit Care Med. 2011;39(6):1388-1393.
26. Gene: FCR2A. Ensembl Genome Browser. http://www.ensembl.org/Homo-sapiens/ Gene/Summary?g=ENSG00000143226;r=1:161475220-161493803. Accessed October 16, 2012.
27. Sanders LA, Feldman RG, Voorhorst-Ogink MM, et al. Human immunoglobulin G (IgG) Fc receptor IIA (CD32) polymorphism and IgG2-mediated bacterial phagocytosis by neutrophils. Infect Immun. 1995;63(1):73-81.
28. Garcia-Vidal C, Ardanuy C, Tubau F, et al. Pneumococcal pneumonia presenting with septic shock: host- and pathogen-related factors and outcomes. Thorax. 2010;65(1):77-81.
29. Rodriguez S, Gaunt TR, Day IN. Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies. Am J Epidemiol. 2009;169(4):505-514.
30. Hattersley AT, McCarthy MI. What makes a good genetic association study? Lancet. 2005;366(9493):1315-1323. (Pubitemid 41416588)
31. Kellum JA, Kong L, Fink MP, et al;GenIMS Investigators. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) study. Arch Intern Med. 2007;167(15):1655-1663. (Pubitemid 47280347)
32. Rodriguez A, Lisboa T, Blot S, et al;Community-Acquired Pneumonia Intensive Care Units (CAPUCI) Study Inves tigators. Mortality in ICU patients with bacterial community-acquired pneumonia: when antibiotics are not enough. Intensive Care Med. 2009;35(3):430-438.
33. Brouwer MC, de Gans J, Heckenberg SG, Zwinderman AH, van der Poll T, van de Beek D. Host genetic susceptibility to pneumococcal and meningococcal disease: a systematic review and meta-analysis. Lancet Infect Dis. 2009;9(1):31-44.
34. Jönsson G, Truedsson L, Sturfelt G, Oxelius VA, Braconier JH, Sjöholm AG. Hereditary C2 deficiency in Sweden: frequent occurrence of invasive infection, atherosclerosis, and rheumatic disease. Medicine (Baltimore). 2005;84(1):23-34. (Pubitemid 40130182)
35. Picard C, Puel A, Bonnet M, et al. Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science. 2003;299(5615):2076-2079. (Pubitemid 36383736)
36. Ku CL, von Bernuth H, Picard C, et al. Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity. J Exp Med. 2007;204(10):2407-2422. (Pubitemid 47529326)
37. Mold C, Du Clos TW. C-reactive protein increases cytokine responses to Streptococcus pneumoniae through interactions with Fc gamma receptors. J Immunol. 2006;176(12):7598-7604. (Pubitemid 43853054)
38. Cañete JD, Suárez B, Hernández MV, et al. Influence of variants of Fc gamma receptors IIA and IIIA on the American College of Rheumatology and European League Against Rheumatism responses to anti-tumour necrosis factor alpha therapy in rheumatoid arthritis. Ann Rheum Dis. 2009;68(10):1547-1552.
39. Hatta M, Yamamoto N, Miyazato A, et al. Early production of tumor necrosis factor-alpha by Gr-1 cells and its role in the host defense to pneumococcal infection in lungs. FEMS Immunol Med Microbiol. 2010;58(2):182-192.
40. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet. 1997;24(1):1-8. (Pubitemid 27050850)
41. Stanilova SA, Miteva LD, Karakolev ZT, Stefanov CS. Interleukin-10-1082 promoter polymorphism in association with cytokine production and sepsis susceptibility. Intensive Care Med. 2006;32(2):260-266. (Pubitemid 43251147)
42. Schaaf BM, Boehmke F, Esnaashari H, et al. Pneumococcal septic shock is associated with the interleukin-10-1082 gene promoter polymorphism. Am J Respir Crit Care Med. 2003;168(4):476-480. (Pubitemid 37046878)
43. Mohler J, Azoulay-Dupuis E, Amory-Rivier C, et al. Streptococcus pneumoniae strain-dependent lung inflammatory responses in a murine model of pneumococcal pneumonia. Intensive Care Med. 2003;29(5):808-816. (Pubitemid 36609575)